Durysta Prices, Coupons, Copay Cards & Patient Assistance
Durysta (bimatoprost ophthalmic) is a member of the ophthalmic glaucoma agents drug class and is commonly used for Glaucoma - Open Angle, and Intraocular Hypertension.
The cost for Durysta 10 mcg intraocular implant is around $2,172 for a supply of 1 implant, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Durysta is available as a brand name drug only, a generic version is not yet available. View generic Durysta availability for more details.
Durysta prices
Intraocular Implant
10 mcg
Durysta intraocular implant
from $2,171.73
for 1 implant
Quantity | Per unit | Price |
---|---|---|
1 | $2,171.73 | $2,171.73 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Durysta Coupons, Copay Cards and Rebates
Durysta offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Durysta Savings Program
Eligible commercially insured patients may pay as little as $0 for one implant per eye; offer applies to implants given during the current program period.
- Applies to:
- Durysta
- Number of uses:
- one implant per eye
Form more information phone: 833-387-9782 or Visit website
Patient Assistance & Copay Programs for Durysta
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: myAbbVie Assist for Eye Care
Eligibility requirements:- Must be uninsured or underinsured
- At or below 600% of FPL
- Not applicable
- Must be a US resident and treated by a US licensed healthcare provider
- Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
- Durysta (bimatoprost implant) Intracameral Administration
More information please phone: 800-222-6885 Visit Website
Provider: Allergan Eyecue: Durysta
Eligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- The patient must be a US citizen or possess a valid greencard to be eligible for this program
- Resources for HEALTHCARE PROFESSIONALS ONLY. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
- Durysta (bimatoprost implant) Intracameral Administration
More information please phone: 844-539-3283 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
More about Durysta (bimatoprost ophthalmic)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
- Breastfeeding
- En español